Company
ChromaCode
Improving health outcomes with access to critical biomarkers for patient management
Also known as ChromaCode, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- physicians and lab partners
- Legal name
- ChromaCode, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Our breakthrough High-Definition PCR (HDPCR™) multiplexing platform has the power to enable transformative genomic solutions. Our products provide physicians and lab partners faster results for improved decision making and better outcomes.
Funding snapshot
- Total raised
- $94.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.8M2025-01-30
Funding rounds
- Round, 2025
- $3.8M2025-01-30, SEC form D sold, 4 investors
- Round, 2022
- $38M2022-02-28, SEC form D sold, 16 investors
- Round, 2019
- $38.6M2019-08-09, SEC form D sold, 17 investors
- Round, 2019
- $1.8M2019-04-04, SEC form D sold, 6 investors
- Round, 2017
- $12M2017-04-17, SEC form D sold, 9 investors
Products
- Web
- ChromaCode Cloud
- Other
- HDPCR
Loading relationship preview